|
Atom Limbs Inc |
|
Innovator in prosthetic technology. |
N/A |
|
|
|
InterMune Inc |
|
Biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. |
N/A |
|
|
|
InterMune Inc |
|
Biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. |
N/A |
|
|
|
InterMune Inc |
|
Biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. |
N/A |
|
|
|
Atom Limbs Inc |
|
Innovator in prosthetic technology. |
N/A |
|
|
|
Atom Limbs Inc |
|
Innovator in prosthetic technology. |
N/A |
|
|
|
InterMune Inc |
|
Biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. |
N/A |
|
|
|
Shire PLC |
|
|
N/A |
|
|
|
Shire PLC |
|
|
N/A |
|
|
|
InterMune Inc |
|
Biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. |
N/A |
|
|
|
20/20 Imaging |
|
Provider of comprehensive digital imaging and IT solutions and services to a large variety of clinical specialties. |
N/A |
|
|
|
Atom Limbs Inc |
|
Innovator in prosthetic technology. |
N/A |
|
|
|
Questcor Pharmaceuticals Inc |
|
|
N/A |
|
|
|
Questcor Pharmaceuticals Inc |
|
|
N/A |
|
|
|
Genosis PLC |
|
Delivering innovative and unique solutions to consumer issues arising in the field of reproductive health |
N/A |
|
|
|
Genosis PLC |
|
Delivering innovative and unique solutions to consumer issues arising in the field of reproductive health |
N/A |
|
|
|
Beijing YiCheng Bio-electronic Technology Co Ltd |
|
Manufacturer of medical products including developing, producing, and marketing of blood glucose meters. |
N/A |
|
|
|
Calliditas Therapeutics AB |
|
Biopharma company focused on identifying, developing, and commercialising novel treatments in orphan indications with significant unmet medical needs. |
Debt |
EUR 68,000,000 |
|
|
Onyx Pharmaceuticals Inc |
|
|
N/A |
|
|
|
Onyx Pharmaceuticals Inc |
|
|
N/A |
|
|